In addition, a total of 17 patients with CBF leukemia (12 AML with RUNX1-RUNX1T1 gene fusion and 5 AML with CBFβ-MYH11 gene fusion) were confirmed via NGS analysis. This evidence concerns the gene RUNX1 and acute myeloid leukemia.